Levophed norepinephrine bitartrate — Class II drug recall D-0898-2017
Terminated recall by Hospira Inc., A Pfizer Company, reported 2017-06-21, distributed nationwide. GMP Deviation; A foreign stopper was observed during packaging of a lot of product.
| Recall number | D-0898-2017 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hospira Inc., A Pfizer Company, Lake Forest, IL, United States |
| Recall initiated | 2017-05-18 |
| Classified | 2017-06-09 |
| Reported by FDA | 2017-06-21 |
| Terminated | 2019-05-02 |
| Distributed | Nationwide (US) |
| Countries outside the US | CA, SG |
| Reason classes | cgmp |
| NDC | 00409-1443, 00409-1443-04, 00409-1443-14, 00409-3375, 00409-3375-04, 00409-3375-14 |
Product
Levophed norepinephrine bitartrate, injection, USP, 4 mg /4 mL (1 mg/mL),Rx only, Hospira, Inc. Lake Forest, IL --- NDC 0409-3375-04
Reason for recall
GMP Deviation; A foreign stopper was observed during packaging of a lot of product.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0898-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.